口服普萘洛尔联合外用西罗莫司治疗浅表卡波状血管内皮瘤一例。

IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE

Vascular Health and Risk Management Pub Date : 2024-06-12 eCollection Date: 2024-01-01 DOI:10.2147/VHRM.S461505

Nan Dang, Yunqing Ren

引用次数: 0

摘要

不伴有卡萨巴赫-梅里特现象的鳞状血管内皮瘤（KHE）是一种罕见的肿瘤，主要见于儿童患者；然而，文献中对该肿瘤的记载仍然有限。我们报道了一名被诊断为浅表 KHE 的 1 岁男孩，他接受了口服普萘洛尔联合外用西罗莫司治疗，并回顾了浅表 KHE 的相关报道和治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus.

Kaposiform hemangioendothelioma(KHE) without Kasabach-Merritt phenomenon is a rare tumor primarily observed in pediatric patients; however, its documentation in the literature remains limited. We reported about a 1-year-old boy diagnosed with superficial KHE who received oral propranolol in combination with topical sirolimus and reviewed relevant reports and treatment of superficial KHE.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vascular Health and Risk Management PERIPHERAL VASCULAR DISEASE-

CiteScore

4.20

自引率

3.40%

发文量

109

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention, and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes. In addition, the journal will also seek to define drug usage in terms of ultimate uptake and acceptance by the patient and healthcare professional.